DSM establishes Biomedical Scientific Advisory Board
Following the installation of a Corporate Scientific Advisory Board in June 2007, DSM has now decided to establish a Biomedical Scientific Advisory Board to support the company in its ambitions to become a world leader in biomedical materials. The Biomedical Scientific Advisory Board will consist of renowned opinion leaders in the sciences and clinical disciplines that DSM Biomedical focuses on.
The first appointed members include Professor Tony Mikos (Rice University, Houston, USA) who will head up the Biomedical Scientific Advisory Board. He is an expert in the synthesis, processing and application development of new biomaterials and has (co)authored over 330 publications. Furthermore Dr. Ivo Buschmann (Charité, University of Medicine, Berlin and Freiburg University, Germany), and Mr. Patrick Cahalan, BSc (Ension Inc., Pittsburgh, USA) have been appointed. Dr. Buschmann is an Assistant Professor and clinical cardiologist and an expert in cardiovascular research. He heads an international research consortium called Art.Net. which focuses on experimental and clinical research in the field of vascular biology and arteriogenesis (collateral artery growth). Mr. Patrick Cahalan is a medical device industry veteran. He has over three decades of R&D experience, particularly in medical coatings, and holds more than 40 granted and pending patents.
Together with the other members, to be appointed in due course, these experts will provide advice to DSM Biomedical on its research and development strategy and program. The advice will include an assessment of R&D programs and projects vis-à-vis scientific and technological quality, validity of hypotheses, and clinical relevance.
Steve Hartig, Vice President DSM Biomedical: "I am convinced that early validation by external thought leaders of our ideas and inventions on scientific merit and relevance will considerably increase the success rate of our biomedical innovations. We are honored that such leading experts as Tony Mikos, Patrick Cahalan and Ivo Buschmann have committed themselves to our Board ."
Other news from the department business & finance
These products might interest you
OCA 200 by DataPhysics
Using contact angle meter to comprehensively characterise wetting behaviour, solids, and liquids
With its intuitive software and as a modular system, the OCA 200 answers to all customers’ needs
Dursan by SilcoTek
Innovative coating revolutionizes LC analysis
Stainless steel components with the performance of PEEK - inert, robust and cost-effective
Tailor-made products for specific applications by IPC Process Center
Granulates and pellets - we develop and manufacture the perfect solution for you
Agglomeration of powders, pelletising of powders and fluids, coating with melts and polymers
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.
Topic world Synthesis
Chemical synthesis is at the heart of modern chemistry and enables the targeted production of molecules with specific properties. By combining starting materials in defined reaction conditions, chemists can create a wide range of compounds, from simple molecules to complex active ingredients.
